Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Repligen Corporation (RGEN)
USD144.89
+0.01 (+0.01%)
US NASDAQ Healthcare Medical - Instruments & Supplies
Address
Building 1 2453
Waltham, MA, US
Waltham, MA, US
CEO
Olivier Loeillot
Website
repligen.com
IPO
1986-04-29
CIK 730272 ISIN US7599161095
Description
Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing. This encompasses Protein A ligands, which serve as the key binding elements within Protein A affinity chromatography resins, as well as specialized cell culture growth factors. In the realm of chromatography, Repligen offers a range of products: Its OPUS line features pre-packed chromatography columns, instrumental in purifying biologics, alongside smaller-scale OPUS columns designed for high-throughput process development screening, viral clearance validation studies, and the scaling-down of chromatography processes. Additionally, the company supplies ELISA test kits and chromatography resins marketed under the CaptivA brand. Repligen also boasts an extensive suite of filtration products. This includes XCell Alternating Tangential Flow systems, which are filtration devices utilized in upstream perfusion and cell culture processing. For downstream applications like biologic drug concentration and formulation, they provide TangenX flat sheet cassettes. Other filtration offerings encompass KrosFlo tangential flow filtration and tangential flow depth filtration systems, Spectra/Por laboratory and process dialysis products, SpectraFlo dynamic dialysis systems, and ProConnex single-use hollow fibers. Furthermore, Repligen addresses process analytics with its slope spectroscopy systems, branded as SoloVPE, FlowVPE, and FlowVPX. Their clientele is broad, consisting of life sciences organizations, biopharmaceutical and diagnostics companies, laboratory researchers, and contract manufacturing organizations. Repligen also collaborates with partners, such as Navigo Proteins GmbH, on the development of various affinity ligands. The corporation was founded in 1981 and maintains its corporate headquarters in Waltham, Massachusetts.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD144.89
+0.01 (+0.01%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
1.08
Float Shares
53.30M
Free Float %
94.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.99% | -10.59% | -5.41% | -14.35% | -28.11% | -30.67% | -15.05% | -25.25% | -33.80% | +331.77% | +909.78% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (23 ratings, all time)
Buy
Price Targets & DCF
Current price
144.89
Low
142.00
-2.0%
Consensus
163.67
+13.0%
Median
152.50
+5.3%
High
200.00
+38.0%
DCF (Unlevered)
32.03
-77.9%
DCF (Levered)
31.82
-78.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
81% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 14 | 0 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 4 |
148.00
+2.1%
|
| Last Quarter | 4 |
148.00
+2.1%
|
| Last Year | 13 |
169.00
+16.6%
|
| All Time | 22 |
179.73
+24.0%
|
Quality scores
Altman Z-Score
6.07
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%+16.4% ★ Q1'26: +14.8% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%+287.0% ★ Q1'26: +50.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+7.2% Q1'26: +12.0% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+11.6% Q1'26: +9.3% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+3.3% Q1'26: +3.6% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%+1.1% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×4.20× ★ Q1'26: 4.04× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 1993 actual |
Dec 2005 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 15 Rev. Ana. 11 EPS Ana. |
Dec 2027 14 Rev. Ana. 10 EPS Ana. |
Dec 2028 11 Rev. Ana. 4 EPS Ana. |
Dec 2029 5 Rev. Ana. 2 EPS Ana. |
Dec 2030 5 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
27.30M
est: 30.82M (-11.4%)
|
9.36M
est: 22.57B (-100.0%)
|
83.54M
est: 81.76M (+2.2%)
|
104.54M
est: 103.53M (+1.0%)
|
141.24M
est: 140.89M (+0.2%)
|
194.03M
est: 192.35M (+0.9%)
|
270.25M
est: 269.14M (+0.4%)
|
366.26M
est: 351.59M (+4.2%)
|
670.53M
est: 664.36M (+0.9%)
|
801.54M
est: 799.57M (+0.2%)
|
632.36M
est: 602.35M (+5.0%)
|
634.44M
est: 634.15M (+0.0%)
|
738.26M
est: 733.09M (+0.7%)
|
823.02M
816.54M – 828.72M
+12.3% YoY
|
943.84M
932.35M – 959.57M
+14.7% YoY
|
1.09B
1.09B – 1.09B
+15.2% YoY
|
1.26B
1.24B – 1.28B
+15.7% YoY
|
1.44B
1.42B – 1.46B
+14.7% YoY
|
| EBITDA |
-16.80M
est: -16.20M (-3.7%)
|
-1.22M
est: 7.82M (-115.6%)
|
22.44M
est: 16.03M (+40.0%)
|
24.55M
est: 17.70M (+38.7%)
|
24.14M
est: 18.23M (+32.4%)
|
41.77M
est: 42.21M (-1.0%)
|
56.31M
est: 41.67M (+35.1%)
|
98.42M
est: 59.22M (+66.2%)
|
203.27M
est: 129.93M (+56.4%)
|
277.31M
est: 191.94M (+44.5%)
|
145.32M
est: 147.94M (-1.8%)
|
80.26M
est: 155.75M (-48.5%)
|
164.30M
est: 180.05M (-8.7%)
|
202.13M
200.54M – 203.53M
+12.3% YoY
|
231.81M
228.98M – 235.67M
+14.7% YoY
|
266.94M
266.62M – 267.25M
+15.2% YoY
|
308.92M
304.84M – 313.52M
+15.7% YoY
|
354.23M
349.55M – 359.51M
+14.7% YoY
|
| EBIT |
-19.20M
est: -14.37M (-33.7%)
|
-1.22M
est: 1.34M (-191.0%)
|
13.46M
est: 11.84M (+13.6%)
|
19.22M
est: 13.52M (+42.2%)
|
13.69M
est: 10.76M (+27.2%)
|
25.99M
est: 24.79M (+4.8%)
|
35.44M
est: 26.12M (+35.7%)
|
71.35M
est: 41.98M (+69.9%)
|
164.82M
est: 105.80M (+55.8%)
|
220.30M
est: 159.71M (+37.9%)
|
59.21M
est: 86.77M (-31.8%)
|
-6.30M
est: 91.35M (-106.9%)
|
85.56M
est: 105.60M (-19.0%)
|
118.55M
117.62M – 119.38M
+12.3% YoY
|
135.96M
134.30M – 138.22M
+14.7% YoY
|
156.56M
156.38M – 156.75M
+15.2% YoY
|
181.19M
178.80M – 183.89M
+15.7% YoY
|
207.76M
205.02M – 210.86M
+14.7% YoY
|
| Net Income |
-11.30M
est: -18.10M (+37.6%)
|
-2.98M
est: 7.11M (-141.9%)
|
9.35M
est: 7.33M (+27.5%)
|
11.68M
est: 9.74M (+19.9%)
|
28.35M
est: 20.79M (+36.4%)
|
16.62M
est: 15.93M (+4.3%)
|
21.41M
est: 15.77M (+35.8%)
|
59.93M
est: 36.77M (+63.0%)
|
128.29M
est: 80.76M (+58.9%)
|
185.96M
est: 123.55M (+50.5%)
|
35.60M
est: -1.90M (+1,972.5%)
|
-25.51M
est: 87.29M (-129.2%)
|
48.89M
est: 94.41M (-48.2%)
|
113.23M
111.51M – 114.94M
+19.9% YoY
|
136.51M
112.21M – 160.81M
+20.6% YoY
|
188.92M
143.73M – 234.11M
+38.4% YoY
|
244.09M
239.90M – 248.82M
+29.2% YoY
|
307.31M
302.04M – 313.27M
+25.9% YoY
|
| SGA |
37.40M
est: 9.61M (+289.1%)
|
4.60M
est: 9.62M (-52.2%)
|
24.70M
est: 24.98M (-1.1%)
|
30.85M
est: 26.35M (+17.1%)
|
51.51M
est: 37.49M (+37.4%)
|
66.32M
est: 63.65M (+4.2%)
|
78.69M
est: 71.38M (+10.3%)
|
93.41M
est: 72.90M (+28.1%)
|
183.87M
est: 118.26M (+55.5%)
|
215.83M
est: 164.18M (+31.5%)
|
218.58M
est: 204.53M (+6.9%)
|
263.37M
est: 215.33M (+22.3%)
|
290.51M
est: 248.92M (+16.7%)
|
279.46M
277.26M – 281.39M
+12.3% YoY
|
320.48M
316.58M – 325.82M
+14.7% YoY
|
369.06M
368.62M – 369.49M
+15.2% YoY
|
427.10M
421.46M – 433.47M
+15.7% YoY
|
489.74M
483.27M – 497.04M
+14.7% YoY
|
| EPS |
-0.93
est: -1.53 (+39.2%)
|
-0.10
est: -0.23 (+55.9%)
|
0.28
est: 0.34 (-18.2%)
|
0.35
est: 0.44 (-20.0%)
|
0.74
est: 0.62 (+20.1%)
|
0.38
est: 0.72 (-47.5%)
|
0.44
est: 1.03 (-57.3%)
|
1.14
est: 1.44 (-20.6%)
|
2.33
est: 2.90 (-19.7%)
|
3.35
est: 3.18 (+5.3%)
|
0.64
est: -0.03 (+1,979.1%)
|
-0.46
est: 1.54 (-129.9%)
|
0.87
est: 1.66 (-47.7%)
|
2.00
1.97 – 2.03
+20.3% YoY
|
2.59
1.98 – 2.84
+29.3% YoY
|
3.28
2.54 – 4.14
+26.6% YoY
|
4.32
4.24 – 4.40
+31.6% YoY
|
5.43
5.34 – 5.54
+25.9% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-06 | JP Morgan | Overweight | Overweight | Maintain |
| 2026-04-20 | Canaccord Genuity | Hold | Hold | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-07 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-06 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-05 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-04 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-01 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-15 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
150.21M
OE per share TTM
2.66
Owner's Yield
2.35%
Maintenance CapEx ratio
65.73%
Maint CapEx / Avg PPE
40.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
109
Total invested
645.18M
Insider transactions (90d)
1
Beneficial owners (>5%)
20
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 5.69M | 10.20% | 5.52M | — | 5.69M | — | HC | Delaware | 2022-09-08 | ↗ |
| 2 | The Vanguard Group - 23-1945930 | 4.91M | 8.89% | — | 31.1K | 4.84M | 77.1K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 3 | Abigail P. Johnson | 3.67M | 11.18% | — | — | 3.67M | — | IN | Delaware | 2015-06-10 | ↗ |
| 4 | Edward C. Johnson 3d | 3.67M | 11.18% | — | — | 3.67M | — | IN | Delaware | 2015-06-10 | ↗ |
| 5 | FMR LLC | 3.67M | 11.18% | 50.1K | — | 3.67M | — | HC | Delaware | 2015-06-10 | ↗ |
| 6 | Roy T. Eddleman | 3.50M | 6.65% | 3.50M | — | 3.50M | — | IN | USA | 2021-02-05 | ↗ |
| 7 | 52-0556948 | 3.04M | 5.50% | 568.7K | — | 3.04M | — | IA | Maryland | 2022-02-14 | ↗ |
| 8 | NorthPointe Capital, LLC | 2.31M | 7.40% | 1.68M | — | 2.31M | — | IA | Delaware | 2013-02-11 | ↗ |
| 9 | Select Biotechnology Portfolio | 1.86M | 5.67% | 1.86M | — | — | — | IV | Delaware | 2015-06-10 | ↗ |
| 10 | Winslow Management Company, LLC | 1.79M | 5.73% | 1.79M | — | 1.79M | — | IA | U.S., Delaware | 2009-02-17 | ↗ |
| 11 | BlackRock for purposes of Schedule 13G filings. | 1.71M | 5.56% | 1.71M | — | 1.71M | — | HC | Delaware | 2010-01-29 | ↗ |
| 12 | OppenheimerFunds, Inc. | 1.68M | 3.86% | — | 1.68M | — | — | IA | Colorado | 2018-02-07 | ↗ |
| 13 | 98-0557567 | 1.67M | 4.90% | 1.66M | — | 1.67M | — | IA, HC | Bermuda | 2017-02-01 | ↗ |
| 14 | Lindsay A. Rosenwald, M.D. | 1.17M | 4.28% | 33.3K | 1.14M | 33.3K | 1.14M | IN | United States | 2003-02-18 | ↗ |
| 15 | Paramount Capital Asset Management, Inc. | 1.14M | 4.17% | — | 1.14M | — | 1.14M | CO | Delaware | 2003-02-18 | ↗ |
| 16 | The Aries Master Fund II | 1.10M | 3.86% | — | 1.10M | — | 1.10M | OO | Cayman Islands | 2003-02-18 | ↗ |
| 17 | Biotechnology Value Fund, L.P.I.R.S. | 461.3K | 1.50% | — | 461.3K | — | 461.3K | EP, IN | Delaware | 2005-05-13 | ↗ |
| 18 | The Aries Domestic Fund II, L.P. | 225.6K | 0.90% | — | 225.6K | — | 225.6K | PN | Delaware | 2001-02-14 | ↗ |
| 19 | Aries Domestic Fund, L.P. | 41.2K | 0.15% | — | 41.2K | — | 41.2K | PN | Delaware | 2003-02-18 | ↗ |
| 20 | TimesSquare Capital Management, LLC | — | 0.00% | — | — | — | — | IA | Delaware | 2019-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
109
-375 vs prev Q
New positions
11
Closed positions
375
Increased
46
Reduced
29
Put/Call ratio
0.00
Calls held
200.00
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 204.9K +204.9K (+100.0%) | 33.57B +33.6B (+100.0%) | 0.36% +0.365 pp | 0.05% +0.051 pp | USD163.86 +0.0% | 1 qtrs NEW |
| 2 | BLACKROCK, INC. | 6.62M +479.5K (+7.8%) | 1.08B +263.9M (+32.2%) | 11.78% +0.848 pp | 0.02% +0.004 pp | USD149.77 +9.4% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 4.99M -50.2K (-1.0%) | 818.31M +144.1M (+21.4%) | 8.88% -0.094 pp | 0.01% +0.002 pp | USD104.80 +56.4% | 84 qtrs — |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | 4.60M +1.1M (+31.1%) | 753.60M +284.8M (+60.7%) | 8.18% +1.939 pp | 0.08% +0.031 pp | USD159.04 +3.0% | 43 qtrs — |
| 5 | FMR LLC | 2.87M +176.6K (+6.6%) | 469.93M +110.2M (+30.6%) | 5.10% +0.312 pp | 0.02% +0.005 pp | USD141.42 +15.9% | 52 qtrs — |
| 6 | UNITED CAPITAL FINANCIAL ADVISERS, LLC | 2.77M +14.9K (+0.5%) | 454.03M +85.6M (+23.2%) | 4.93% +0.024 pp | 2.73% +0.090 pp | USD133.83 +22.4% | 2 qtrs — |
| 7 | STATE STREET CORP | 1.72M -82.4K (-4.6%) | 281.69M +40.9M (+17.0%) | 3.06% -0.148 pp | 0.01% +0.001 pp | USD98.38 +66.6% | 51 qtrs — |
| 8 | CITADEL ADVISORS LLC | 1.39M -290.5K (-17.2%) | 228.46M +3.3M (+1.5%) | 2.48% -0.518 pp | 0.03% +0.000 pp | USD140.17 +16.9% | 33 qtrs — |
| 9 | BANK OF NEW YORK MELLON CORP | 1.34M +28.9K (+2.2%) | 220.34M +44.5M (+25.3%) | 2.39% +0.050 pp | 0.04% +0.005 pp | USD127.89 +28.1% | 66 qtrs — |
| 10 | INVESCO LTD. | 1.26M +383.4K (+43.9%) | 205.88M +89.2M (+76.4%) | 2.24% +0.681 pp | 0.03% +0.013 pp | USD139.11 +17.8% | 51 qtrs — |
| 11 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.22M +1.2M (+100.0%) | 199.18M +199.2M (+100.0%) | 2.16% +2.163 pp | 0.06% +0.064 pp | USD163.86 +0.0% | 1 qtrs NEW |
| 12 | FRANKLIN RESOURCES INC | 1.10M +677.1K (+159.6%) | 180.48M +123.8M (+218.2%) | 1.96% +1.204 pp | 0.04% +0.030 pp | USD159.50 +2.7% | 26 qtrs — |
| 13 | RTW INVESTMENTS, LP | 1.06M +1.1M (+100.0%) | 174.35M +174.3M (+100.0%) | 1.89% +1.893 pp | 1.75% +1.746 pp | USD163.86 +0.0% | 1 qtrs NEW |
| 14 | CONESTOGA CAPITAL ADVISORS, LLC | 1.06M +101.1K (+10.6%) | 173.36M +45.4M (+35.5%) | 1.88% +0.179 pp | 2.92% +0.865 pp | USD95.59 +71.4% | 47 qtrs — |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 1.03M -2.6K (-0.3%) | 168.78M +30.7M (+22.3%) | 1.83% -0.006 pp | 0.01% +0.002 pp | USD102.21 +60.3% | 78 qtrs — |
| 16 | POINT72 ASSET MANAGEMENT, L.P. | 1.01M -434.4K (-30.2%) | 164.89M -27.7M (-14.4%) | 1.79% -0.774 pp | 0.18% -0.138 pp | USD140.00 +17.0% | 30 qtrs — |
| 17 | CHAMPLAIN INVESTMENT PARTNERS, LLC | 1.00M -335.3K (-25.0%) | 164.51M -14.5M (-8.1%) | 1.79% -0.598 pp | 1.67% +0.316 pp | USD156.17 +4.9% | 14 qtrs — |
| 18 | ALLIANCEBERNSTEIN L.P. | 994.9K -109.3K (-9.9%) | 163.02M +15.4M (+10.5%) | 1.77% -0.196 pp | 0.05% +0.005 pp | USD140.64 +16.5% | 54 qtrs — |
| 19 | HOLOCENE ADVISORS, LP | 961.0K -416.1K (-30.2%) | 157.48M -26.6M (-14.5%) | 1.71% -0.742 pp | 0.33% -0.089 pp | USD132.98 +23.2% | 5 qtrs — |
| 20 | FRED ALGER MANAGEMENT, LLC | 911.5K +553.1K (+154.3%) | 149.36M +101.5M (+211.8%) | 1.62% +0.984 pp | 0.59% +0.399 pp | USD152.29 +7.6% | 35 qtrs — |
| 21 | DIMENSIONAL FUND ADVISORS LP | 804.4K +4.9K (+0.6%) | 131.82M +25.0M (+23.4%) | 1.43% +0.008 pp | 0.03% +0.005 pp | USD104.98 +56.1% | 51 qtrs — |
| 22 | CONGRESS ASSET MANAGEMENT CO /MA | 746.3K +527.7K (+241.4%) | 122.29M +93.1M (+318.5%) | 1.33% +0.939 pp | 0.86% +0.666 pp | USD161.52 +1.4% | 30 qtrs — |
| 23 | STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 657.1K +58.8K (+9.8%) | 107.67M +27.7M (+34.6%) | 1.17% +0.104 pp | 1.40% +0.365 pp | USD75.14 +118.1% | 43 qtrs — |
| 24 | MILLENNIUM MANAGEMENT LLC | 650.5K -166.5K (-20.4%) | 106.60M -2.6M (-2.4%) | 1.16% -0.297 pp | 0.04% -0.002 pp | USD125.72 +30.3% | 31 qtrs — |
| 25 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 646.1K +74.0K (+12.9%) | 105.87M +29.4M (+38.5%) | 1.15% +0.131 pp | 0.07% +0.020 pp | USD134.78 +21.6% | 14 qtrs — |
| 26 | MORGAN STANLEY | 571.0K +86.0K (+17.7%) | 93.56M +28.7M (+44.3%) | 1.02% +0.153 pp | 0.01% +0.002 pp | USD161.86 +1.2% | 51 qtrs — |
| 27 | GENEVA CAPITAL MANAGEMENT LLC | 563.0K -33.8K (-5.7%) | 92.25M +12.5M (+15.6%) | 1.00% -0.061 pp | 1.73% +0.365 pp | USD127.94 +28.1% | 24 qtrs — |
| 28 | BAMCO INC /NY/ | 544.8K +163.1K (+42.7%) | 89.27M +38.2M (+75.0%) | 0.97% +0.290 pp | 0.24% +0.107 pp | USD148.30 +10.5% | 14 qtrs — |
| 29 | VOYA INVESTMENT MANAGEMENT LLC | 521.2K +218.5K (+72.2%) | 85.40M +44.9M (+111.1%) | 0.93% +0.389 pp | 0.08% +0.044 pp | USD152.63 +7.4% | 47 qtrs — |
| 30 | MARSHALL WACE, LLP | 516.3K +335.3K (+185.2%) | 84.61M +60.4M (+249.6%) | 0.92% +0.596 pp | 0.08% +0.053 pp | USD155.76 +5.2% | 29 qtrs — |
| 31 | DF DENT & CO INC | 495.6K -39.2K (-7.3%) | 81.20M +9.7M (+13.6%) | 0.88% -0.070 pp | 1.17% +0.245 pp | USD149.83 +9.4% | 24 qtrs — |
| 32 | AMERIPRISE FINANCIAL INC | 494.2K -15.4K (-3.0%) | 80.98M +12.9M (+18.9%) | 0.88% -0.028 pp | 0.02% +0.003 pp | USD171.65 -4.5% | 55 qtrs — |
| 33 | NORGES BANK | 462.1K +462.1K (+100.0%) | 75.72M +75.7M (+100.0%) | 0.82% +0.822 pp | 0.01% +0.008 pp | USD163.86 +0.0% | 1 qtrs NEW |
| 34 | NORTHERN TRUST CORP | 446.1K -18.0K (-3.9%) | 73.11M +11.1M (+17.8%) | 0.79% -0.032 pp | 0.01% +0.001 pp | USD91.12 +79.8% | 51 qtrs — |
| 35 | SCHRODER INVESTMENT MANAGEMENT GROUP | 443.9K -16.7K (-3.6%) | 72.74M +11.2M (+18.1%) | 0.79% -0.030 pp | 0.06% +0.008 pp | USD129.51 +26.5% | 3 qtrs — |
| 36 | TIMESSQUARE CAPITAL MANAGEMENT, LLC | 435.7K +73.6K (+20.3%) | 71.39M +23.0M (+47.5%) | 0.78% +0.131 pp | 1.08% +0.383 pp | USD152.09 +7.7% | 12 qtrs — |
| 37 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 430.7K +8.6K (+2.0%) | 70.58M +14.2M (+25.1%) | 0.77% +0.015 pp | 0.01% +0.002 pp | USD94.72 +73.0% | 56 qtrs — |
| 38 | WALLEYE CAPITAL LLC | 417.1K +231.4K (+124.5%) | 68.35M +43.5M (+175.3%) | 0.74% +0.411 pp | 0.21% +0.117 pp | USD150.02 +9.2% | 8 qtrs — |
| 39 | IMPAX ASSET MANAGEMENT GROUP PLC | 413.4K -289.9K (-41.2%) | 67.74M -25.3M (-27.2%) | 0.74% -0.516 pp | 0.42% -0.119 pp | USD157.09 +4.3% | 24 qtrs — |
| 40 | THRIVENT FINANCIAL FOR LUTHERANS | 411.7K -47.1K (-10.3%) | 67.46M +6.1M (+10.0%) | 0.73% -0.084 pp | 0.12% -0.001 pp | USD138.26 +18.5% | 47 qtrs — |
| 41 | ARTEMIS INVESTMENT MANAGEMENT LLP | 410.4K +63.6K (+18.3%) | 67.24M +20.9M (+45.1%) | 0.73% +0.113 pp | 0.81% +0.236 pp | USD145.87 +12.3% | 9 qtrs — |
| 42 | BANK OF AMERICA CORP /DE/ | 397.2K +7.8K (+2.0%) | 65.09M +13.0M (+25.1%) | 0.71% +0.014 pp | 0.00% +0.001 pp | USD127.44 +28.6% | 52 qtrs — |
| 43 | UBS GROUP AG | 348.4K -108.5K (-23.8%) | 57.09M -4.0M (-6.5%) | 0.62% -0.194 pp | 0.01% 0.000 pp | USD139.35 +17.6% | 45 qtrs — |
| 44 | AMERICAN CAPITAL MANAGEMENT INC | 335.1K -1.7K (-0.5%) | 54.91M +9.9M (+21.9%) | 0.60% -0.003 pp | 2.42% +0.629 pp | USD124.25 +31.9% | 30 qtrs — |
| 45 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 323.8K +40.4K (+14.2%) | 53.06M +15.2M (+40.0%) | 0.58% +0.072 pp | 0.06% -0.037 pp | USD167.57 -2.2% | 20 qtrs — |
| 46 | JANE STREET GROUP, LLC | 321.4K -64.6K (-16.7%) | 52.66M +1.1M (+2.1%) | 0.57% -0.115 pp | 0.01% +0.000 pp | USD132.90 +23.3% | 6 qtrs — |
| 47 | IRON TRIANGLE PARTNERS LP | 320.5K +50.5K (+18.7%) | 52.51M +16.4M (+45.5%) | 0.57% +0.090 pp | 6.00% +0.872 pp | USD138.42 +18.4% | 2 qtrs — |
| 48 | PERCEPTIVE ADVISORS LLC | 315.5K +45.1K (+16.7%) | 51.70M +15.6M (+43.0%) | 0.56% +0.080 pp | 0.92% -0.122 pp | USD134.28 +22.0% | 4 qtrs — |
| 49 | RIVERBRIDGE PARTNERS LLC | 313.4K -30.1K (-8.8%) | 51.35M +5.4M (+11.9%) | 0.56% -0.054 pp | 0.96% +0.188 pp | USD146.50 +11.8% | 11 qtrs — |
| 50 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 311.2K +7.4K (+2.4%) | 51.14M +6.9M (+15.5%) | 0.55% +0.013 pp | 0.08% +0.012 pp | USD154.46 +6.1% | 17 qtrs — |
| 51 | BLUE WHALE CAPITAL LLP | 308.5K +65.4K (+26.9%) | 50.55M +18.1M (+55.5%) | 0.55% +0.116 pp | 2.59% +0.797 pp | USD132.75 +23.4% | 3 qtrs — |
| 52 | GOLDMAN SACHS GROUP INC | 295.3K +174.8K (+145.0%) | 48.38M +32.3M (+200.4%) | 0.53% +0.311 pp | 0.01% +0.004 pp | USD149.46 +9.6% | 49 qtrs — |
| 53 | FIRST TRUST ADVISORS LP | 282.8K +16.5K (+6.2%) | 46.34M +10.7M (+30.2%) | 0.50% +0.029 pp | 0.03% +0.007 pp | USD169.05 -3.1% | 30 qtrs — |
| 54 | BROWN CAPITAL MANAGEMENT LLC | 274.0K -394.9K (-59.0%) | 44.89M -44.5M (-49.8%) | 0.49% -0.703 pp | 3.68% -0.002 pp | USD172.82 -5.2% | 20 qtrs — |
| 55 | AMERICAN CENTURY COMPANIES INC | 250.3K -2.5K (-1.0%) | 41.01M +7.2M (+21.4%) | 0.45% -0.005 pp | 0.02% +0.003 pp | USD172.66 -5.1% | 23 qtrs — |
| 56 | JPMORGAN CHASE & CO | 248.9K -24.5K (-9.0%) | 40.79M +4.2M (+11.6%) | 0.44% -0.044 pp | 0.00% +0.000 pp | USD139.69 +17.3% | 43 qtrs — |
| 57 | 12 WEST CAPITAL MANAGEMENT LP | 241.2K +— (+0.0%) | 39.53M +7.3M (+22.6%) | 0.43% 0.000 pp | 4.71% +1.363 pp | USD83.39 +96.5% | 27 qtrs — |
| 58 | PALISADE CAPITAL MANAGEMENT, LP | 232.2K -29.6K (-11.3%) | 38.05M +3.1M (+8.7%) | 0.41% -0.053 pp | 1.13% +0.177 pp | USD80.98 +102.3% | 44 qtrs — |
| 59 | BAIRD FINANCIAL GROUP, INC. | 205.6K -11.6K (-5.3%) | 33.69M +4.7M (+16.0%) | 0.37% -0.021 pp | 0.05% +0.006 pp | USD152.53 +7.4% | 23 qtrs — |
| 60 | NZS CAPITAL, LLC | 198.8K +2.0K (+1.0%) | 32.58M +6.3M (+23.8%) | 0.35% +0.003 pp | 1.00% +0.194 pp | USD144.14 +13.7% | 11 qtrs — |
| 61 | PRINCIPAL FINANCIAL GROUP INC | 198.2K +80.8K (+68.8%) | 32.48M +16.8M (+106.9%) | 0.35% +0.144 pp | 0.02% +0.009 pp | USD147.47 +11.1% | 55 qtrs — |
| 62 | ARTISAN PARTNERS LIMITED PARTNERSHIP | 193.7K -19.0K (-9.0%) | 31.74M +3.3M (+11.6%) | 0.34% -0.034 pp | 0.05% +0.007 pp | USD154.62 +6.0% | 24 qtrs — |
| 63 | NUVEEN, LLC | 192.7K +55.4K (+40.3%) | 31.57M +13.2M (+72.0%) | 0.34% +0.098 pp | 0.01% +0.003 pp | USD137.88 +18.8% | 4 qtrs — |
| 64 | PRIMECAP MANAGEMENT CO/CA/ | 186.7K -200.0 (-0.1%) | 30.59M +5.6M (+22.5%) | 0.33% -0.001 pp | 0.02% +0.004 pp | USD137.43 +19.2% | 19 qtrs — |
| 65 | SEI INVESTMENTS CO | 182.0K -33.0K (-15.4%) | 29.82M +1.1M (+3.7%) | 0.32% -0.059 pp | 0.03% -0.002 pp | USD162.50 +0.8% | 42 qtrs — |
| 66 | NEW YORK STATE COMMON RETIREMENT FUND | 171.0K -76.5K (-30.9%) | 28.02M -5.1M (-15.3%) | 0.30% -0.136 pp | 0.04% -0.005 pp | USD144.33 +13.5% | 47 qtrs — |
| 67 | RAYMOND JAMES FINANCIAL INC | 168.9K +18.7K (+12.5%) | 27.88M +7.8M (+38.9%) | 0.30% +0.033 pp | 0.01% +0.002 pp | USD146.15 +12.1% | 5 qtrs — |
| 68 | UBS ASSET MANAGEMENT AMERICAS INC | 164.4K -213.0 (-0.1%) | 26.93M +4.9M (+22.4%) | 0.29% -0.001 pp | 0.01% +0.001 pp | USD126.99 +29.0% | 46 qtrs — |
| 69 | RANGER INVESTMENT MANAGEMENT, L.P. | 162.5K -515.0 (-0.3%) | 26.62M +4.8M (+22.2%) | 0.29% -0.001 pp | 1.83% +0.307 pp | USD91.61 +78.9% | 41 qtrs — |
| 70 | BARCLAYS PLC | 159.2K +132.8K (+503.0%) | 26.08M +22.2M (+563.9%) | 0.28% +0.236 pp | 0.01% +0.005 pp | USD159.93 +2.5% | 51 qtrs — |
| 71 | MOORE CAPITAL MANAGEMENT, LP | 150.0K +5.0K (+3.4%) | 24.58M +5.2M (+26.8%) | 0.27% +0.009 pp | 0.35% +0.087 pp | USD134.68 +21.7% | 2 qtrs — |
| 72 | LOOMIS SAYLES & CO L P | 149.8K -18.3K (-10.9%) | 24.54M +2.1M (+9.3%) | 0.27% -0.033 pp | 0.03% +0.003 pp | USD127.87 +28.1% | 3 qtrs — |
| 73 | COMERICA BANK | 149.1K +36.0K (+31.9%) | 24.43M +9.3M (+61.7%) | 0.27% +0.064 pp | 0.10% +0.041 pp | USD151.53 +8.1% | 11 qtrs — |
| 74 | SEGALL BRYANT & HAMILL, LLC | 147.0K +7.6K (+5.5%) | 24.08M +5.5M (+29.3%) | 0.26% +0.013 pp | 0.33% +0.078 pp | USD143.16 +14.5% | 5 qtrs — |
| 75 | ROYCE & ASSOCIATES LP | 147.0K -1.7K (-1.1%) | 24.08M +4.2M (+21.2%) | 0.26% -0.003 pp | 0.24% +0.046 pp | USD128.08 +27.9% | 3 qtrs — |
| 76 | ROYAL BANK OF CANADA | 143.3K -96.5K (-40.2%) | 23.49M -8.6M (-26.7%) | 0.26% -0.172 pp | 0.00% -0.001 pp | USD129.24 +26.8% | 51 qtrs — |
| 77 | PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 134.6K +— (+0.0%) | 22.05M +4.1M (+22.6%) | 0.24% 0.000 pp | 0.08% +0.015 pp | USD176.85 -7.3% | 33 qtrs — |
| 78 | RHUMBLINE ADVISERS | 134.1K -5.5K (-3.9%) | 21.98M +3.3M (+17.8%) | 0.24% -0.010 pp | 0.02% +0.003 pp | USD63.66 +157.4% | 55 qtrs — |
| 79 | DAIWA SECURITIES GROUP INC. | 130.3K +79.0K (+154.3%) | 21.35M +14.5M (+211.7%) | 0.23% +0.141 pp | 0.07% +0.045 pp | USD153.94 +6.4% | 13 qtrs — |
| 80 | JENNISON ASSOCIATES LLC | 123.6K +123.6K (+100.0%) | 20.25M +20.3M (+100.0%) | 0.22% +0.220 pp | 0.01% +0.012 pp | USD163.86 +0.0% | 1 qtrs NEW |
| 81 | RMB CAPITAL MANAGEMENT, LLC | 117.9K -4.4K (-3.6%) | 19.32M +3.0M (+18.2%) | 0.21% -0.008 pp | 0.33% +0.035 pp | USD97.00 +68.9% | 35 qtrs — |
| 82 | BALYASNY ASSET MANAGEMENT L.P. | 115.1K -652.2K (-85.0%) | 18.85M -83.7M (-81.6%) | 0.20% -1.161 pp | 0.02% -0.106 pp | USD131.96 +24.2% | 4 qtrs — |
| 83 | AGF MANAGEMENT LTD | 111.6K +111.6K (+100.0%) | 18.29M +18.3M (+100.0%) | 0.20% +0.199 pp | 0.08% +0.079 pp | USD163.86 +0.0% | 1 qtrs NEW |
| 84 | VICTORY CAPITAL MANAGEMENT INC | 109.1K +42.3K (+63.3%) | 17.87M +8.9M (+100.2%) | 0.19% +0.075 pp | 0.01% +0.005 pp | USD143.48 +14.2% | 40 qtrs — |
| 85 | SWISS NATIONAL BANK | 105.4K +2.0K (+1.9%) | 17.27M +3.4M (+25.0%) | 0.19% +0.004 pp | 0.01% +0.002 pp | USD114.41 +43.2% | 47 qtrs — |
| 86 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | 101.9K -19.5K (-16.0%) | 16.71M +478.0K (+2.9%) | 0.18% -0.035 pp | 0.13% +0.002 pp | USD138.41 +18.4% | 14 qtrs — |
| 87 | ENSIGN PEAK ADVISORS, INC | 101.2K -14.6K (-12.6%) | 16.58M +1.1M (+7.2%) | 0.18% -0.026 pp | 0.03% +0.004 pp | USD153.39 +6.8% | 25 qtrs — |
| 88 | ENVESTNET ASSET MANAGEMENT INC | 101.1K -3.1K (-3.0%) | 16.57M +2.6M (+18.9%) | 0.18% -0.006 pp | 0.00% +0.001 pp | USD175.70 -6.7% | 42 qtrs — |
| 89 | LORD, ABBETT & CO. LLC | 90.2K +90.2K (+100.0%) | 14.79M +14.8M (+100.0%) | 0.16% +0.161 pp | 0.05% +0.045 pp | USD163.86 +0.0% | 1 qtrs NEW |
| 90 | ADVISOR GROUP HOLDINGS, INC. | 90.0K +53.8K (+148.7%) | 14.74M +9.9M (+205.6%) | 0.16% +0.096 pp | 0.02% +0.015 pp | USD152.36 +7.5% | 24 qtrs — |
| 91 | NORTH STAR ASSET MANAGEMENT INC | 84.9K -536.0 (-0.6%) | 13.91M +2.5M (+21.8%) | 0.15% -0.001 pp | 0.56% +0.098 pp | USD53.02 +209.1% | 36 qtrs — |
| 92 | KORNITZER CAPITAL MANAGEMENT INC /KS | 83.8K +5.5K (+7.0%) | 13.73M +3.3M (+31.2%) | 0.15% +0.010 pp | 0.29% +0.075 pp | USD135.65 +20.8% | 2 qtrs — |
| 93 | CITIGROUP INC | 83.8K +32.2K (+62.4%) | 13.72M +6.8M (+99.1%) | 0.15% +0.057 pp | 0.01% +0.003 pp | USD146.70 +11.7% | 56 qtrs — |
| 94 | VESTAL POINT CAPITAL, LP | 83.0K -317.0K (-79.3%) | 13.60M -39.9M (-74.6%) | 0.15% -0.564 pp | 0.46% -1.952 pp | USD133.67 +22.6% | 2 qtrs — |
| 95 | BRAIDWELL LP | 81.8K -113.9K (-58.2%) | 13.40M -12.8M (-48.8%) | 0.15% -0.203 pp | 0.43% -0.347 pp | USD133.23 +23.0% | 11 qtrs — |
| 96 | LEGAL & GENERAL GROUP PLC | 78.8K -5.0K (-6.0%) | 12.91M +1.7M (+15.3%) | 0.14% -0.009 pp | 0.00% +0.000 pp | USD160.84 +1.9% | 46 qtrs — |
| 97 | BNP PARIBAS ARBITRAGE, SNC | 74.0K -155.7K (-67.8%) | 12.13M -18.6M (-60.5%) | 0.13% -0.277 pp | 0.01% -0.011 pp | USD135.63 +20.8% | 51 qtrs — |
| 98 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 72.8K -36.1K (-33.1%) | 11.93M -2.6M (-18.1%) | 0.13% -0.064 pp | 0.00% 0.000 pp | USD140.77 +16.4% | 51 qtrs — |
| 99 | GRANAHAN INVESTMENT MANAGEMENT, LLC | 72.0K +2.1K (+3.0%) | 11.80M +2.5M (+26.3%) | 0.13% +0.004 pp | 0.51% +0.123 pp | USD142.69 +14.8% | 16 qtrs — |
| 100 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 70.1K -137.0 (-0.2%) | 11.49M +2.1M (+22.3%) | 0.12% 0.000 pp | 0.01% +0.001 pp | USD105.06 +56.0% | 58 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
1
Shares acquired
—
Shares disposed
3.8K
Cash buys
—
Cash sales
1.00
Net activity
-3,832
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-21 | Loeillot Olivier | Director / Officer | S-Sale | D | Common Stock | 3,832 | 140.00 | 536.5K | 54,246 | D | ↗ |
| 2026-03-05 | Loeillot Olivier | Officer | A-Award | A | Stock Option (Right to Buy) | 25,890 | 141.91 | 3.67M | 25,890 | D | ↗ |
| 2026-03-05 | KURIYEL RALF | Officer | A-Award | A | Stock Option (Right to Buy) | 5,669 | 141.91 | 804.5K | 5,669 | D | ↗ |
| 2026-03-05 | Garland Jason K | Officer | A-Award | A | Stock Option (Right to Buy) | 8,315 | 141.91 | 1.18M | 8,315 | D | ↗ |
| 2026-03-05 | Bylund James | Officer | A-Award | A | Stock Option (Right to Buy) | 8,315 | 141.91 | 1.18M | 8,315 | D | ↗ |
| 2026-03-04 | KURIYEL RALF | Officer | A-Award | A | Common Stock | 125 | 0.00 | — | 14,820 | D | ↗ |
| 2026-03-04 | Bylund James | Officer | A-Award | A | Common Stock | 125 | 0.00 | — | 17,734 | D | ↗ |
| 2026-03-02 | Loeillot Olivier | Director / Officer | F-InKind | D | Common Stock | 1,610 | 124.97 | 201.2K | 33,944 | D | ↗ |
| 2026-03-02 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 923 | 124.97 | 115.3K | 14,695 | D | ↗ |
| 2026-03-02 | Hunt Anthony | Director | F-InKind | D | Common Stock | 9,897 | 124.97 | 1.24M | 89,062 | D | ↗ |
| 2026-03-02 | Garland Jason K | Officer | F-InKind | D | Common Stock | 715 | 124.97 | 89.4K | 12,341 | D | ↗ |
| 2026-03-02 | Douglass Brian Robb | Officer | F-InKind | D | Common Stock | 221 | 124.97 | 27.6K | 8,319 | D | ↗ |
| 2026-03-02 | Bylund James | Officer | F-InKind | D | Common Stock | 2,433 | 124.97 | 304.1K | 17,609 | D | ↗ |
| 2026-02-27 | Loeillot Olivier | Director / Officer | F-InKind | D | Common Stock | 344 | 128.73 | 44.3K | 35,554 | D | ↗ |
| 2026-02-27 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 444 | 128.73 | 57.2K | 15,618 | D | ↗ |
| 2026-02-27 | Garland Jason K | Officer | F-InKind | D | Common Stock | 327 | 128.73 | 42.1K | 13,056 | D | ↗ |
| 2026-02-27 | Bylund James | Officer | F-InKind | D | Common Stock | 1,478 | 128.73 | 190.3K | 20,042 | D | ↗ |
| 2025-12-31 | Douglass Brian Robb | Officer | A-Award | A | Common Stock | 2,288 | 0.00 | — | 8,540 | D | ↗ |
| 2025-12-17 | DAWES KAREN A | Director | S-Sale | D | Common Stock | 275 | 161.00 | 44.3K | 91,821 | D | ↗ |
| 2025-12-16 | MUIR GLENN P | Director | M-Exempt | A | Stock Option (Right to Buy) | 3,366 | 26.12 | 87.9K | 3,366 | D | ↗ |
| 2025-12-04 | Hunt Anthony | Director | J-Other | D | Common Stock | 2,000 | 0.00 | — | 98,959 | D | ↗ |
| 2025-11-25 | Loeillot Olivier | Director / Officer | S-Sale | D | Common Stock | 7,041 | 170.00 | 1.20M | 35,898 | D | ↗ |
| 2025-11-18 | Bylund James | Officer | S-Sale | D | Common Stock | 2,191 | 151.21 | 331.3K | 21,520 | D | ↗ |
| 2025-11-13 | Hunt Anthony | Director | S-Sale | D | Common Stock | 1,784 | 151.01 | 269.4K | 98,959 | D | ↗ |
| 2025-11-12 | Hunt Anthony | Director | S-Sale | D | Common Stock | 4,959 | 156.65 | 776.8K | 112,303 | D | ↗ |
| 2025-10-02 | Loeillot Olivier | Director / Officer | F-InKind | D | Common Stock | 1,248 | 145.23 | 181.2K | 42,939 | D | ↗ |
| 2025-09-25 | Garland Jason K | Officer | F-InKind | D | Common Stock | 412 | 121.68 | 50.1K | 13,383 | D | ↗ |
| 2025-09-10 | Hunt Anthony | Director | S-Sale | D | Common Stock | 14,882 | 120.19 | 1.79M | 110,506 | D | ↗ |
| 2025-09-03 | Loeillot Olivier | Director / Officer | F-InKind | D | Common Stock | 2,506 | 116.18 | 291.1K | 44,187 | D | ↗ |
| 2025-09-02 | Hughes Violetta | Officer | A-Award | A | Stock Option (Right to Buy) | 3,914 | 120.69 | 472.4K | 3,914 | D | ↗ |
| 2025-09-01 | Hughes Violetta | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-08-08 | Madaus Martin D | Director | P-Purchase | A | Common Stock | 1,800 | 112.13 | 201.8K | 1,800 | I | ↗ |
| 2025-05-15 | Pax Margaret | Director | A-Award | A | Stock Option (Right to Buy) | 1,800 | 123.26 | 221.9K | 1,800 | D | ↗ |
| 2025-05-15 | Mhatre Rohin | Director | A-Award | A | Common Stock | 973 | 0.00 | — | 4,019 | D | ↗ |
| 2025-05-15 | Madaus Martin D | Director | A-Award | A | Stock Option (Right to Buy) | 1,800 | 123.26 | 221.9K | 1,800 | D | ↗ |
| 2025-05-15 | MUIR GLENN P | Director | A-Award | A | Common Stock | 973 | 0.00 | — | 33,256 | D | ↗ |
| 2025-05-15 | Konstantinov Konstantin | Director | A-Award | A | Common Stock | 973 | 0.00 | — | 2,894 | D | ↗ |
| 2025-05-15 | Hunt Anthony | Director | S-Sale | D | Common Stock | 2,043 | 122.66 | 250.6K | 134,258 | D | ↗ |
| 2025-05-15 | EGLINTON MANNER CARRIE | Director | A-Award | A | Stock Option (Right to Buy) | 1,800 | 123.26 | 221.9K | 1,800 | D | ↗ |
| 2025-05-15 | DAWES KAREN A | Director | A-Award | A | Stock Option (Right to Buy) | 1,800 | 123.26 | 221.9K | 1,800 | D | ↗ |
| 2025-05-15 | BARTHELEMY NICOLAS | Director | A-Award | A | Stock Option (Right to Buy) | 1,800 | 123.26 | 221.9K | 1,800 | D | ↗ |
| 2025-04-01 | Bylund James | Officer | F-InKind | D | Common Stock | 454 | 128.50 | 58.3K | 23,711 | D | ↗ |
| 2025-03-17 | Pax Margaret | Director | P-Purchase | A | Common Stock | 250 | 150.69 | 37.7K | 1,043 | D | ↗ |
| 2025-03-17 | Hunt Anthony | Director | S-Sale | D | Common Stock | 15,619 | 152.82 | 2.39M | 138,584 | D | ↗ |
| 2025-03-13 | Bylund James | Officer | F-InKind | D | Common Stock | 175 | 142.44 | 24.9K | 24,165 | D | ↗ |
| 2025-03-03 | Loeillot Olivier | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 13,627 | 155.38 | 2.12M | 13,627 | D | ↗ |
| 2025-03-03 | KURIYEL RALF | Officer | A-Award | A | Stock Option (Right to Buy) | 4,542 | 155.38 | 705.7K | 4,542 | D | ↗ |
| 2025-03-03 | Hunt Anthony | Director | F-InKind | D | Common Stock | 10,142 | 155.38 | 1.58M | 136,301 | D | ↗ |
| 2025-03-03 | Garland Jason K | Officer | A-Award | A | Stock Option (Right to Buy) | 6,056 | 155.38 | 941.0K | 6,056 | D | ↗ |
| 2025-03-03 | Bylund James | Officer | A-Award | A | Stock Option (Right to Buy) | 6,056 | 155.38 | 941.0K | 6,056 | D | ↗ |
| 2025-02-27 | Loeillot Olivier | Director / Officer | F-InKind | D | Common Stock | 343 | 156.54 | 53.7K | 32,213 | D | ↗ |
| 2025-02-27 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 391 | 156.54 | 61.2K | 11,622 | D | ↗ |
| 2025-02-27 | Hunt Anthony | Director | F-InKind | D | Common Stock | 2,825 | 156.54 | 442.2K | 146,443 | D | ↗ |
| 2025-02-27 | Garland Jason K | Officer | F-InKind | D | Common Stock | 316 | 156.54 | 49.5K | 7,360 | D | ↗ |
| 2025-02-27 | Bylund James | Officer | F-InKind | D | Common Stock | 1,285 | 156.54 | 201.2K | 18,763 | D | ↗ |
| 2025-02-24 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 275 | 164.74 | 45.3K | 12,013 | D | ↗ |
| 2025-02-24 | Hunt Anthony | Director | F-InKind | D | Common Stock | 2,380 | 164.74 | 392.1K | 149,268 | D | ↗ |
| 2025-02-24 | Bylund James | Officer | F-InKind | D | Common Stock | 543 | 164.74 | 89.5K | 20,048 | D | ↗ |
| 2024-12-05 | Hunt Anthony | Director | M-Exempt | A | Common Stock | 11,808 | 33.87 | 399.9K | 151,648 | D | ↗ |
| 2024-11-21 | Hunt Anthony | Director | S-Sale | D | Common Stock | 24,246 | 139.67 | 3.39M | 139,840 | D | ↗ |
| 2024-11-20 | Loeillot Olivier | Director / Officer | F-InKind | D | Common Stock | 861 | 123.41 | 106.3K | 32,556 | D | ↗ |
| 2024-11-20 | Garland Jason K | Officer | F-InKind | D | Common Stock | 367 | 123.41 | 45.3K | 7,676 | D | ↗ |
| 2024-11-19 | MUIR GLENN P | Director | M-Exempt | A | Common Stock | 19,000 | 36.29 | 689.5K | 32,283 | D | ↗ |
| 2024-09-10 | Hunt Anthony | Director | S-Sale | D | Common Stock | 604 | 146.67 | 88.6K | 139,840 | — | ↗ |
| 2024-09-03 | Loeillot Olivier | Director / Officer | A-Award | A | Common Stock | 17,631 | 0.00 | — | 33,417 | — | ↗ |
| 2024-09-03 | Hunt Anthony | Director | D-Return | D | Common Stock | 13,146 | 0.00 | — | 152,031 | — | ↗ |
| 2024-08-02 | KURIYEL RALF | Officer | M-Exempt | A | Common Stock | 175 | 86.10 | 15.1K | 12,463 | — | ↗ |
| 2024-08-01 | MUIR GLENN P | Director | M-Exempt | A | Stock Option (Right to Buy) | 5,000 | 36.29 | 181.5K | 0 | — | ↗ |
| 2024-08-01 | KURIYEL RALF | Officer | S-Sale | D | Common Stock | 4,465 | 165.67 | 739.7K | 19,261 | — | ↗ |
| 2024-06-14 | Madaus Martin D | Director | P-Purchase | A | Common Stock | 700 | 125.46 | 87.8K | 4,613 | — | ↗ |
| 2024-06-14 | Hunt Anthony | Officer | P-Purchase | A | Common Stock | 2,000 | 124.08 | 248.2K | 165,177 | — | ↗ |
| 2024-06-14 | DAWES KAREN A | Director | M-Exempt | A | Stock Option (Right to Buy) | 2,953 | 67.71 | 199.9K | 0 | — | ↗ |
| 2024-06-14 | BARTHELEMY NICOLAS | Director | P-Purchase | A | Common Stock | 1,200 | 125.45 | 150.5K | 4,668 | — | ↗ |
| 2024-05-21 | Hunt Anthony | Officer | S-Sale | D | Common Stock | 4,274 | 166.36 | 711.0K | 178,975 | — | ↗ |
| 2024-05-16 | Pax Margaret | Director | A-Award | A | Common Stock | 701 | 0.00 | — | 793 | — | ↗ |
| 2024-05-16 | Mhatre Rohin | Director | A-Award | A | Stock Option (Right to Buy) | 1,376 | 171.03 | 235.3K | 1,376 | — | ↗ |
| 2024-05-16 | Madaus Martin D | Director | A-Award | A | Stock Option (Right to Buy) | 1,376 | 171.03 | 235.3K | 1,376 | — | ↗ |
| 2024-05-16 | MUIR GLENN P | Director | A-Award | A | Common Stock | 701 | 0.00 | — | 8,283 | — | ↗ |
| 2024-05-16 | Konstantinov Konstantin | Director | A-Award | A | Stock Option (Right to Buy) | 1,376 | 171.03 | 235.3K | 1,376 | — | ↗ |
| 2024-05-16 | EGLINTON MANNER CARRIE | Director | A-Award | A | Stock Option (Right to Buy) | 1,376 | 171.03 | 235.3K | 1,376 | — | ↗ |
| 2024-05-16 | DAWES KAREN A | Director | A-Award | A | Stock Option (Right to Buy) | 1,576 | 171.03 | 269.5K | 1,576 | — | ↗ |
| 2024-05-16 | BARTHELEMY NICOLAS | Director | A-Award | A | Stock Option (Right to Buy) | 1,376 | 171.03 | 235.3K | 1,376 | — | ↗ |
| 2024-05-14 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 534 | 163.34 | 87.2K | 23,726 | — | ↗ |
| 2024-05-14 | Gebski Christine | Officer | F-InKind | D | Common Stock | 334 | 163.34 | 54.6K | 27,419 | — | ↗ |
| 2024-04-02 | Bylund James | Officer | F-InKind | D | Common Stock | 444 | 182.95 | 81.2K | 20,591 | — | ↗ |
| 2024-03-18 | Pax Margaret | Director | A-Award | A | Stock Option (Right to Buy) | 2,236 | 194.25 | 434.3K | 2,236 | — | ↗ |
| 2024-03-18 | Hunt Anthony | Officer | G-Gift | D | Common Stock | 2,000 | 0.00 | — | 183,249 | — | ↗ |
| 2024-03-11 | KURIYEL RALF | Officer | M-Exempt | A | Common Stock | 1,271 | 86.10 | 109.4K | 27,777 | — | ↗ |
| 2024-03-08 | Hunt Anthony | Officer | S-Sale | D | Common Stock | 6,228 | 196.32 | 1.22M | 192,351 | — | ↗ |
| 2024-03-07 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 386 | 195.72 | 75.5K | 26,506 | — | ↗ |
| 2024-03-07 | Hunt Anthony | Officer | F-InKind | D | Common Stock | 2,867 | 195.72 | 561.1K | 201,955 | — | ↗ |
| 2024-03-07 | Gebski Christine | Officer | F-InKind | D | Common Stock | 386 | 195.72 | 75.5K | 27,753 | — | ↗ |
| 2024-03-07 | Bylund James | Officer | F-InKind | D | Common Stock | 1,206 | 195.72 | 236.0K | 21,035 | — | ↗ |
| 2024-03-05 | Hunt Anthony | Officer | F-InKind | D | Common Stock | 7,275 | 195.52 | 1.42M | 204,822 | — | ↗ |
| 2024-03-05 | Bylund James | Officer | F-InKind | D | Common Stock | 22 | 195.52 | 4.3K | 22,241 | — | ↗ |
| 2024-03-04 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 135 | 193.99 | 26.2K | 26,892 | — | ↗ |
| 2024-03-04 | Hunt Anthony | Officer | F-InKind | D | Common Stock | 1,111 | 193.99 | 215.5K | 212,097 | — | ↗ |
| 2024-03-04 | Gebski Christine | Officer | F-InKind | D | Common Stock | 131 | 193.99 | 25.4K | 28,139 | — | ↗ |
| 2024-03-04 | Bylund James | Officer | F-InKind | D | Common Stock | 197 | 193.99 | 38.2K | 22,263 | — | ↗ |
| 2024-03-01 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 453 | 191.79 | 86.9K | 27,027 | — | ↗ |
| 2024-03-01 | Hunt Anthony | Officer | F-InKind | D | Common Stock | 3,322 | 191.79 | 637.1K | 213,208 | — | ↗ |
| 2024-03-01 | Gebski Christine | Officer | F-InKind | D | Common Stock | 447 | 191.79 | 85.7K | 28,731 | — | ↗ |
| 2024-03-01 | Bylund James | Officer | A-Award | A | Common Stock | 50 | 0.00 | — | 22,460 | — | ↗ |
| 2024-02-29 | KURIYEL RALF | Officer | A-Award | A | Common Stock | 404 | 0.00 | — | 27,480 | — | ↗ |
| 2024-02-29 | Hunt Anthony | Officer | A-Award | A | Common Stock | 2,504 | 0.00 | — | 216,530 | — | ↗ |
| 2024-02-29 | Gebski Christine | Officer | A-Award | A | Common Stock | 391 | 0.00 | — | 29,178 | — | ↗ |
| 2024-02-29 | Bylund James | Officer | A-Award | A | Common Stock | 404 | 0.00 | — | 23,230 | — | ↗ |
| 2024-02-27 | Loeillot Olivier | Officer | A-Award | A | Stock Option (Right to Buy) | 2,860 | 192.71 | 551.2K | 2,860 | — | ↗ |
| 2024-02-27 | KURIYEL RALF | Officer | A-Award | A | Stock Option (Right to Buy) | 3,497 | 192.71 | 673.9K | 3,497 | — | ↗ |
| 2024-02-27 | Hunt Anthony | Officer | A-Award | A | Stock Option (Right to Buy) | 19,585 | 192.71 | 3.77M | 19,585 | — | ↗ |
| 2024-02-27 | Garland Jason K | Officer | A-Award | A | Common Stock | 2,540 | 0.00 | — | 8,043 | — | ↗ |
| 2024-02-27 | DAWES KAREN A | Director | S-Sale | D | Common Stock | 1,000 | 193.35 | 193.4K | 87,367 | — | ↗ |
| 2024-02-27 | Bylund James | Officer | A-Award | A | Stock Option (Right to Buy) | 8,632 | 192.71 | 1.66M | 8,632 | — | ↗ |
| 2024-02-23 | Bylund James | Officer | M-Exempt | A | Stock Option (Right to Buy) | 940 | 94.33 | 88.7K | 4,000 | — | ↗ |
| 2023-11-14 | Hunt Anthony | Officer | G-Gift | D | Common Stock | 1,000 | 0.00 | — | 194,307 | — | ↗ |
| 2023-11-10 | Gebski Christine | Officer | S-Sale | D | Common Stock | 3,788 | 147.13 | 557.3K | 28,787 | — | ↗ |
| 2023-10-02 | Loeillot Olivier | Officer | A-Award | A | Stock Option (Right to Buy) | 24,236 | 154.96 | 3.76M | 24,236 | — | ↗ |
| 2023-09-25 | Garland Jason K | Officer | A-Award | A | Stock Option (Right to Buy) | 10,524 | 158.99 | 1.67M | 10,524 | — | ↗ |
| 2023-08-29 | DAWES KAREN A | Director | M-Exempt | A | Common Stock | 7,392 | 18.12 | 133.9K | 84,591 | — | ↗ |
| 2023-05-18 | Mhatre Rohin | Director | A-Award | A | Stock Option (Right to Buy) | 1,487 | 156.63 | 232.9K | 1,487 | — | ↗ |
| 2023-05-18 | Madaus Martin D | Director | A-Award | A | Stock Option (Right to Buy) | 1,487 | 156.63 | 232.9K | 1,487 | — | ↗ |
| 2023-05-18 | MUIR GLENN P | Director | A-Award | A | Common Stock | 686 | 0.00 | — | 7,582 | — | ↗ |
| 2023-05-18 | Konstantinov Konstantin | Director | A-Award | A | Stock Option (Right to Buy) | 1,487 | 156.63 | 232.9K | 1,487 | — | ↗ |
| 2023-05-18 | EGLINTON MANNER CARRIE | Director | A-Award | A | Common Stock | 686 | 0.00 | — | 2,167 | — | ↗ |
| 2023-05-18 | DAWES KAREN A | Director | A-Award | A | Common Stock | 798 | 0.00 | — | 77,199 | — | ↗ |
| 2023-05-18 | BARTHELEMY NICOLAS | Director | A-Award | A | Common Stock | 686 | 0.00 | — | 2,767 | — | ↗ |
| 2023-05-16 | Snodgres Jon | Officer | F-InKind | D | Common Stock | 710 | 154.03 | 109.4K | 37,381 | — | ↗ |
| 2023-05-16 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 710 | 154.03 | 109.4K | 23,556 | — | ↗ |
| 2023-05-16 | Gebski Christine | Officer | F-InKind | D | Common Stock | 334 | 154.03 | 51.4K | 32,575 | — | ↗ |
| 2023-05-08 | Madaus Martin D | Director | P-Purchase | A | Common Stock | 500 | 156.18 | 78.1K | 1,611 | — | ↗ |
| 2023-05-05 | Madaus Martin D | Director | P-Purchase | A | Common Stock | 500 | 159.19 | 79.6K | 1,111 | — | ↗ |
| 2023-05-04 | Madaus Martin D | Director | P-Purchase | A | Common Stock | 500 | 161.15 | 80.6K | 611 | — | ↗ |
| 2023-04-04 | Bylund James | Officer | F-InKind | D | Common Stock | 334 | 163.45 | 54.6K | 17,568 | — | ↗ |
| 2023-03-24 | Madaus Martin D | Director | L-Small | A | Common Stock | 11 | 186.22 | 2.0K | 11 | — | ↗ |
| 2023-03-03 | Snodgres Jon | Officer | F-InKind | D | Common Stock | 3,674 | 188.00 | 690.7K | 38,091 | — | ↗ |
| 2023-03-03 | KURIYEL RALF | Officer | A-Award | A | Common Stock | 3,591 | 0.00 | — | 25,513 | — | ↗ |
| 2023-03-03 | Hunt Anthony | Director / Officer | A-Award | A | Common Stock | 18,584 | 0.00 | — | 203,551 | — | ↗ |
| 2023-03-03 | Gebski Christine | Officer | F-InKind | D | Common Stock | 126 | 188.00 | 23.7K | 32,909 | — | ↗ |
| 2023-03-03 | Bylund James | Officer | A-Award | A | Common Stock | 625 | 0.00 | — | 18,112 | — | ↗ |
| 2023-03-02 | Snodgres Jon | Officer | A-Award | A | Stock Option (Right to Buy) | 5,019 | 180.48 | 905.8K | 5,019 | — | ↗ |
| 2023-03-02 | KURIYEL RALF | Officer | A-Award | A | Common Stock | 3,468 | 0.00 | — | 21,922 | — | ↗ |
| 2023-03-02 | Hunt Anthony | Director / Officer | F-InKind | D | Common Stock | 6,670 | 176.37 | 1.18M | 165,574 | — | ↗ |
| 2023-03-02 | Gebski Christine | Officer | F-InKind | D | Common Stock | 630 | 174.37 | 109.9K | 29,193 | — | ↗ |
| 2023-03-02 | Bylund James | Officer | A-Award | A | Common Stock | 8,348 | 0.00 | — | 17,487 | — | ↗ |
| 2023-02-28 | Snodgres Jon | Officer | F-InKind | D | Common Stock | 521 | 173.28 | 90.3K | 28,122 | — | ↗ |
| 2023-02-28 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 458 | 173.44 | 79.4K | 18,812 | — | ↗ |
| 2023-02-28 | Hunt Anthony | Director / Officer | F-InKind | D | Common Stock | 2,748 | 173.28 | 476.2K | 172,244 | — | ↗ |
| 2023-02-28 | Gebski Christine | Officer | F-InKind | D | Common Stock | 460 | 173.28 | 79.7K | 29,823 | — | ↗ |
| 2023-02-28 | Bylund James | Officer | F-InKind | D | Common Stock | 594 | 173.44 | 103.0K | 9,139 | — | ↗ |
| 2023-02-16 | Snodgres Jon | Officer | S-Sale | D | Common Stock | 5,647 | 200.00 | 1.13M | 29,325 | — | ↗ |
| 2023-02-06 | Madaus Martin D | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-11 | Hunt Anthony | Officer | M-Exempt | A | Common Stock | 25,000 | 33.87 | 846.8K | 203,265 | — | ↗ |
| 2022-10-07 | Snodgres Jon | Officer | M-Exempt | A | Common Stock | 466 | 59.52 | 27.7K | 34,972 | — | ↗ |
| 2022-09-09 | DAWES KAREN A | Director | S-Sale | D | Common Stock | 775 | 227.17 | 176.1K | 76,401 | — | ↗ |
| 2022-09-08 | Hunt Anthony | Officer | M-Exempt | A | Stock Option (Right to Buy) | 10,000 | 0.00 | — | 59,246 | — | ↗ |
| 2022-08-16 | Snodgres Jon | Officer | S-Sale | D | Common Stock | 4,298 | 252.70 | 1.09M | 36,906 | — | ↗ |
| 2022-08-11 | KURIYEL RALF | Officer | S-Sale | D | Common Stock | 4,040 | 254.14 | 1.03M | 19,270 | — | ↗ |
| 2022-08-04 | Gebski Christine | Officer | S-Sale | D | Common Stock | 3,357 | 243.01 | 815.8K | 30,735 | — | ↗ |
| 2022-08-03 | Bylund James | Officer | S-Sale | D | Common Stock | 2,000 | 240.40 | 480.8K | 9,733 | — | ↗ |
| 2022-08-01 | Snodgres Jon | Officer | S-Sale | D | Common Stock | 2,000 | 220.00 | 440.0K | 37,187 | — | ↗ |
| 2022-07-21 | Hunt Anthony | Officer | S-Sale | D | Common Stock | 24,802 | 200.00 | 4.96M | 194,667 | — | ↗ |
| 2022-05-26 | Mhatre Rohin | Director | A-Award | A | Stock Option (Right to Buy) | 2,920 | 159.17 | 464.8K | 2,920 | — | ↗ |
| 2022-05-26 | MUIR GLENN P | Director | A-Award | A | Stock Option (Right to Buy) | 1,298 | 0.00 | — | 1,298 | — | ↗ |
| 2022-05-26 | Konstantinov Konstantin | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-05-26 | EGLINTON MANNER CARRIE | Director | A-Award | A | Stock Option (Right to Buy) | 2,488 | 159.17 | 396.0K | 2,488 | — | ↗ |
| 2022-05-26 | DAWES KAREN A | Director | A-Award | A | Stock Option (Right to Buy) | 1,565 | 0.00 | — | 1,565 | — | ↗ |
| 2022-05-26 | BARTHELEMY NICOLAS | Director | A-Award | A | Stock Option (Right to Buy) | 1,298 | 159.17 | 206.6K | 1,298 | — | ↗ |
| 2022-05-25 | DAWES KAREN A | Director | S-Sale | D | Common Stock | 7,677 | 150.19 | 1.15M | 80,994 | — | ↗ |
| 2022-05-13 | Snodgres Jon | Officer | F-InKind | D | Common Stock | 712 | 150.40 | 107.1K | 39,187 | — | ↗ |
| 2022-05-13 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 712 | 150.40 | 107.1K | 20,110 | — | ↗ |
| 2022-05-13 | Gebski Christine | Officer | F-InKind | D | Common Stock | 335 | 150.40 | 50.4K | 34,092 | — | ↗ |
| 2022-04-01 | Bylund James | Officer | F-InKind | D | Common Stock | 335 | 188.02 | 63.0K | 9,733 | — | ↗ |
| 2022-03-16 | EGLINTON MANNER CARRIE | Director | P-Purchase | A | Common Stock | 625 | 175.02 | 109.4K | 2,106 | — | ↗ |
| 2022-03-08 | Snodgres Jon | Officer | M-Exempt | A | Common Stock | 1,214 | 59.52 | 72.3K | 39,899 | — | ↗ |
| 2022-03-01 | RYAN THOMAS F JR | Director | S-Sale | D | Common Stock | 1,000 | 198.48 | 198.5K | 2,457 | — | ↗ |
| 2022-03-01 | Hunt Anthony | Officer | F-InKind | D | Common Stock | 7,292 | 194.06 | 1.42M | 199,315 | — | ↗ |
| 2022-02-28 | Snodgres Jon | Officer | F-InKind | D | Common Stock | 2,468 | 196.70 | 485.5K | 35,733 | — | ↗ |
| 2022-02-28 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 473 | 196.70 | 93.0K | 18,172 | — | ↗ |
| 2022-02-28 | Hunt Anthony | Director / Officer | F-InKind | D | Common Stock | 3,170 | 196.70 | 623.5K | 189,901 | — | ↗ |
| 2022-02-28 | Gebski Christine | Officer | F-InKind | D | Common Stock | 598 | 196.70 | 117.6K | 34,427 | — | ↗ |
| 2022-02-27 | Snodgres Jon | Officer | F-InKind | D | Common Stock | 695 | 196.70 | 136.7K | 32,940 | — | ↗ |
| 2022-02-27 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 477 | 196.70 | 93.8K | 18,645 | — | ↗ |
| 2022-02-27 | Hunt Anthony | Director / Officer | F-InKind | D | Common Stock | 2,754 | 196.70 | 541.7K | 193,071 | — | ↗ |
| 2022-02-27 | Gebski Christine | Officer | F-InKind | D | Common Stock | 462 | 196.70 | 90.9K | 35,025 | — | ↗ |
| 2022-02-24 | Snodgres Jon | Officer | A-Award | A | Stock Option (Right to Buy) | 4,410 | 189.21 | 834.4K | 4,410 | — | ↗ |
| 2022-02-24 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 188 | 189.21 | 35.6K | 19,122 | — | ↗ |
| 2022-02-24 | Hunt Anthony | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 20,307 | 189.21 | 3.84M | 20,307 | — | ↗ |
| 2022-02-24 | Gebski Christine | Officer | A-Award | A | Stock Option (Right to Buy) | 2,721 | 189.21 | 514.8K | 2,721 | — | ↗ |
| 2022-02-24 | Bylund James | Officer | F-InKind | D | Common Stock | 188 | 189.21 | 35.6K | 10,068 | — | ↗ |
| 2022-02-17 | Snodgres Jon | Officer | A-Award | A | Common Stock | 900 | 0.00 | — | 30,793 | — | ↗ |
| 2022-02-17 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 175 | 182.42 | 31.9K | 17,184 | — | ↗ |
| 2022-02-17 | Gebski Christine | Officer | A-Award | A | Common Stock | 450 | 0.00 | — | 33,768 | — | ↗ |
| 2022-02-17 | Bylund James | Officer | F-InKind | D | Common Stock | 334 | 182.42 | 60.9K | 6,890 | — | ↗ |
| 2021-12-14 | KURIYEL RALF | Officer | F-InKind | D | Common Stock | 445 | 252.53 | 112.4K | 16,909 | — | ↗ |
| 2021-11-18 | Hunt Anthony | Director / Officer | S-Sale | D | Common Stock | 6,024 | 278.08 | 1.68M | 183,706 | — | ↗ |
| 2021-11-10 | DAWES KAREN A | Director | S-Sale | D | Common Stock | 336 | 264.21 | 88.8K | 92,839 | — | ↗ |
| 2021-11-04 | RYAN THOMAS F JR | Director | S-Sale | D | Common Stock | 1,000 | 288.00 | 288.0K | 12,337 | — | ↗ |
| 2021-11-02 | RYAN THOMAS F JR | Director | M-Exempt | A | Stock Option (Right to Buy) | 1,285 | 128.18 | 164.7K | 0 | — | ↗ |
| 2021-11-02 | DAWES KAREN A | Director | S-Sale | D | Common Stock | 251 | 301.20 | 75.6K | 93,332 | — | ↗ |
| 2021-10-29 | BARTHELEMY NICOLAS | Director | M-Exempt | A | Common Stock | 1,285 | 128.18 | 164.7K | 3,192 | — | ↗ |
Executive team
Top executives
EBIT / Employee
48.1K
Shares Outstanding
56.40M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Olivier Loeillot President and Chief Executive Officer | 860.0K | — | 3.37M | 1.10M | 774.0K | 10.3K | 6.11M | 73.11% | ↗ |
| 2 | 2025 | Jason K. Garland Chief Financial Officer | 566.5K | — | 1.50M | 486.9K | 430.2K | 5.0K | 2.99M | 66.48% | ↗ |
| 3 | 2025 | James Bylund Chief Operating Officer | 481.2K | — | 1.59M | 486.9K | 365.4K | 9.4K | 2.93M | 70.81% | ↗ |
| 4 | 2025 | Ralf Kuriyel Senior Vice President, Research and Development | 420.5K | — | 1.21M | 365.2K | 319.4K | 9.2K | 2.33M | 67.83% | ↗ |
| 5 | 2025 | Brian Douglass Senior Vice President, Chief Product Officer | 417.2K | — | 912.3K | 184.4K | 212.7K | 8.2K | 1.73M | 63.22% | ↗ |
| 6 | 2024 | Tony J. Hunt Former Chief Executive Officer | 733.3K | — | 9.31M | 9.60M | 652.8K | 5.0K | 20.30M | 93.15% | ↗ |
| 7 | 2024 | Olivier Loeillot President and Chief Executive Officer | 650.0K | — | 4.58M | 1.45M | 494.6K | 5.0K | 7.18M | 84.00% | ↗ |
| 8 | 2024 | James Bylund Chief Operating Officer | 467.2K | — | 2.51M | 842.3K | 343.9K | 5.0K | 4.17M | 80.43% | ↗ |
| 9 | 2024 | Jason K. Garland Chief Financial Officer | 550.0K | — | 734.2K | 246.2K | 389.4K | 187.6K | 2.11M | 46.52% | ↗ |
| 10 | 2024 | Ralf Kuriyel Senior Vice President, Research and Development | 396.7K | — | 1.02M | 341.2K | 233.6K | 5.0K | 1.99M | 68.14% | ↗ |
| 11 | 2024 | Christine Gebski Former Senior Vice President, Filtration and Chromatography | 279.6K | 75.2K | 200.0K | — | 125.1K | 5.0K | 684.8K | 29.20% | ↗ |
| 12 | 2023 | Tony J. Hunt Chief Executive Officer | 880.0K | — | 5.25M | 1.79M | — | 5.0K | 7.93M | 88.84% | ↗ |
| 13 | 2023 | Tony J. Hunt Former Chief Executive Officer | 880.0K | — | 5.25M | 1.79M | — | 5.0K | 7.93M | 88.84% | ↗ |
| 14 | 2023 | Olivier Loeillot President and Chief Commercial Officer | 138.5K | 1.35M | 2.00M | 1.96M | — | — | 5.45M | 72.66% | ↗ |
| 15 | 2023 | Olivier Loeillot President and Chief Executive Officer | 138.5K | 1.35M | 2.00M | 1.96M | — | — | 5.45M | 72.66% | ↗ |
| 16 | 2023 | James Bylund Chief Operating Officer | 467.2K | — | 2.50M | 772.4K | — | 5.0K | 3.74M | 87.39% | ↗ |
| 17 | 2023 | Jon K. Snodgres Former Chief Financial Officer | 410.0K | — | 1.31M | 448.5K | — | — | 2.17M | 81.11% | ↗ |
| 18 | 2023 | Jason K. Garland Chief Financial Officer | 137.5K | 100.0K | 874.9K | 868.6K | — | 45.5K | 2.03M | 86.04% | ↗ |
| 19 | 2023 | Ralf Kuriyel Senior Vice President, Research and Development | 396.7K | — | 938.9K | 320.9K | — | 5.0K | 1.66M | 75.82% | ↗ |
| 20 | 2023 | Christine Gebski Senior Vice President, Filtration and Chromatography | 391.1K | — | 938.7K | 320.8K | — | 5.0K | 1.66M | 76.07% | ↗ |
| 21 | 2023 | Christine Gebski Former Senior Vice President, Filtration and Chromatography | 391.1K | — | 938.7K | 320.8K | — | 5.0K | 1.66M | 76.07% | ↗ |
| 22 | 2022 | Tony J. Hunt Chief Executive Officer | 800.0K | — | 4.50M | 1.62M | 785.4K | 5.0K | 7.71M | 79.38% | ↗ |
| 23 | 2022 | Tony J. Hunt Former Chief Executive Officer | 800.0K | — | 4.50M | 1.62M | 785.4K | 5.0K | 7.71M | 79.38% | ↗ |
| 24 | 2022 | Jon K. Snodgres Former Chief Financial Officer | 465.4K | 100.0K | 1.24M | 352.6K | 268.5K | 5.0K | 2.43M | 65.43% | ↗ |
| 25 | 2022 | James Bylund Chief Operating Officer | 424.7K | 75.5K | 1.21M | 344.8K | 315.1K | 5.0K | 2.38M | 65.51% | ↗ |
| 26 | 2022 | Ralf Kuriyel Senior Vice President, Research and Development | 374.3K | 81.5K | 796.9K | 217.7K | 201.0K | 5.0K | 1.68M | 60.52% | ↗ |
| 27 | 2022 | Christine Gebski Senior Vice President, Filtration and Chromatography | 365.5K | 59.0K | 796.3K | 217.6K | 196.3K | 5.0K | 1.64M | 61.84% | ↗ |
| 28 | 2022 | Christine Gebski Former Senior Vice President, Filtration and Chromatography | 365.5K | 59.0K | 796.3K | 217.6K | 196.3K | 5.0K | 1.64M | 61.84% | ↗ |
| 29 | 2021 | Tony J. Hunt Chief Executive Officer | 761.0K | — | 4.50M | 1.16M | 1.34M | 5.0K | 7.77M | 72.94% | ↗ |
| 30 | 2021 | Jon K. Snodgres Former Chief Financial Officer | 433.0K | — | 1.24M | 268.7K | 422.1K | 5.0K | 2.37M | 63.74% | ↗ |
| 31 | 2021 | James Bylund Chief Operating Officer | 363.0K | — | 930.4K | 187.7K | 357.6K | 5.0K | 1.84M | 60.65% | ↗ |
| 32 | 2021 | Ralf Kuriyel Senior Vice President, Research and Development | 363.4K | — | 829.1K | 187.9K | 339.8K | 5.0K | 1.73M | 58.95% | ↗ |
| 33 | 2021 | Christine Gebski Senior Vice President, Filtration and Chromatography | 351.5K | — | 804.9K | 181.7K | 328.6K | 5.0K | 1.67M | 59.02% | ↗ |
| 34 | 2017 | Tony J. Hunt President and Chief Executive Officer | 550.0K | — | 1.05M | 983.4K | 453.8K | 5.0K | 3.04M | 66.87% | ↗ |
| 35 | 2017 | Jon K. Snodgres Chief Financial Officer | 350.1K | — | 320.0K | 298.9K | 230.3K | 5.0K | 1.20M | 51.39% | ↗ |
| 36 | 2017 | Howard Benjamin Former Vice President, Business Development | 293.1K | — | 146.0K | 136.4K | 154.3K | 5.0K | 734.8K | 38.43% | ↗ |
| 37 | 2016 | Tony J. Hunt President and Chief Executive Officer | 500.0K | — | 875.0K | 881.4K | 401.3K | 2.0K | 2.66M | 66.04% | ↗ |
| 38 | 2016 | Jon K. Snodgres Chief Financial Officer | 339.5K | — | 205.9K | 207.4K | 181.8K | 2.0K | 936.7K | 44.13% | ↗ |
| 39 | 2016 | Howard Benjamin Former Vice President, Business Development | 287.0K | — | 163.2K | 164.3K | 123.0K | 2.0K | 739.5K | 44.29% | ↗ |
| 40 | 2016 | Name and Position | — | — | — | — | — | — | — | — | ↗ |
| 41 | 2015 | Tony J. Hunt President and Chief Executive Officer | 403.8K | — | 531.2K | 554.2K | 297.0K | 2.0K | 1.79M | 60.70% | ↗ |
| 42 | 2015 | Tony J. Hunt President and Chief Executive Officer | 403.8K | — | 531.2K | 554.2K | 297.0K | 2.0K | 1.79M | 60.70% | ↗ |
| 43 | 2015 | Walter C. Herlihy Former President and Chief Executive Officer | 490.0K | — | 78.1K | 536.0K | — | 136.4K | 1.24M | 49.50% | ↗ |
| 44 | 2015 | Jon K. Snodgres Chief Financial Officer | 330.0K | — | 155.8K | 162.5K | 174.9K | 2.0K | 825.1K | 38.57% | ↗ |
| 45 | 2015 | Jon K. Snodgres Chief Financial Officer | 330.0K | — | 155.8K | 162.5K | 174.9K | 2.0K | 825.1K | 38.57% | ↗ |
| 46 | 2015 | James R. Rusche Senior Vice President, Research and Development | 311.0K | — | 137.0K | 142.9K | 124.4K | 2.0K | 717.3K | 39.02% | ↗ |
| 47 | 2015 | Howard Benjamin Former Vice President, Business Development | 279.0K | — | 122.9K | 128.2K | 120.5K | 2.0K | 652.6K | 38.48% | ↗ |
| 48 | 2015 | Howard Benjamin Vice President, Business Development | 279.0K | — | 122.9K | 128.2K | 120.5K | 2.0K | 652.6K | 38.48% | ↗ |
| 49 | 2014 | Walter C. Herlihy Former President and Chief Executive Officer | 490.0K | — | 392.0K | 392.1K | 366.3K | 2.0K | 1.64M | 47.74% | ↗ |
| 50 | 2014 | Tony J. Hunt President and Chief Executive Officer | 218.7K | — | 413.8K | 433.9K | 139.3K | — | 1.21M | 70.30% | ↗ |
| 51 | 2014 | James R. Rusche Senior Vice President, Research and Development | 302.0K | — | 105.7K | 105.7K | 138.9K | 2.0K | 654.4K | 32.31% | ↗ |
| 52 | 2014 | Howard Benjamin Vice President, Business Development | 271.0K | — | 94.9K | 94.9K | 124.7K | 2.0K | 587.4K | 32.30% | ↗ |
| 53 | 2014 | Jon K. Snodgres Chief Financial Officer | 150.8K | — | 122.5K | 127.9K | 81.6K | 77.0K | 559.8K | 44.72% | ↗ |
| 54 | 2014 | Name and Position | — | — | — | — | — | — | — | — | ↗ |
| 55 | 2013 | Walter C. Herlihy President and Chief Executive Officer | 475.0K | — | — | 277.5K | 285.0K | 2.0K | 1.04M | 26.69% | ↗ |
| 56 | 2013 | Walter C. Herlihy Former President and Chief Executive Officer | 475.0K | — | — | 277.5K | 285.0K | 2.0K | 1.04M | 26.69% | ↗ |
| 57 | 2013 | James R. Rusche Senior Vice President, Research and Development | 293.0K | — | — | 130.6K | 114.9K | 2.0K | 540.4K | 24.16% | ↗ |
| 58 | 2013 | Jonathan . Lieber Chief Financial Officer | 207.0K | — | — | 147.4K | — | 166.5K | 520.9K | 28.29% | ↗ |
| 59 | 2013 | Daniel P. Witt Senior Vice President, Global Operations | 272.5K | — | — | 130.6K | 106.8K | 2.0K | 511.9K | 25.51% | ↗ |
| 60 | 2013 | Howard Benjamin Vice President, Business Development | 262.5K | — | — | 130.6K | 105.0K | 2.0K | 500.1K | 26.11% | ↗ |
| 61 | 2013 | Howard Benjamin Vice President, Business Development | 262.5K | — | — | 130.6K | 105.0K | 2.0K | 500.1K | 26.11% | ↗ |
| 62 | 2013 | William J. Kelly Chief Accounting Officer | 240.5K | — | — | 130.6K | 92.4K | 2.0K | 465.4K | 28.06% | ↗ |
| 63 | 2012 | Walter C. Herlihy President and Chief Executive Officer | 433.0K | — | — | — | 207.2K | 2.0K | 642.2K | 0.00% | ↗ |
| 64 | 2012 | Jonathan I. Lieber Chief Financial Officer | 77.3K | — | 89.7K | 341.2K | 25.3K | 2.0K | 535.6K | 80.46% | ↗ |
| 65 | 2012 | James R. Rusche Senior Vice President, Research and Development | 270.0K | — | — | — | 83.3K | 2.0K | 355.3K | 0.00% | ↗ |
| 66 | 2012 | Daniel P. Witt Senior Vice President, Global Operations | 250.0K | — | — | — | 77.2K | 2.0K | 329.2K | 0.00% | ↗ |
| 67 | 2012 | William J. Kelly Chief Accounting Officer | 210.0K | — | — | — | 64.8K | 2.0K | 276.8K | 0.00% | ↗ |
| 68 | 2011 | Walter C. Herlihy President and Chief Executive Officer | 383.5K | 52.0K | — | 97.4K | 159.2K | 2.0K | 694.0K | 14.03% | ↗ |
| 69 | 2011 | Walter C. Herlihy, Ph.D. President and Chief Executive Officer | 383.5K | 52.0K | — | 97.4K | 159.2K | 2.0K | 694.0K | 14.03% | ↗ |
| 70 | 2011 | James R. Rusche Senior Vice President, Research and Development | 258.0K | 18.7K | — | 48.7K | 63.3K | 2.0K | 390.7K | 12.46% | ↗ |
| 71 | 2011 | James R. Rusche, Ph.D. Senior Vice President, Research and Development | 258.0K | 18.7K | — | 48.7K | 63.3K | 2.0K | 390.7K | 12.46% | ↗ |
| 72 | 2011 | Daniel P. Witt, Ph.D. Vice President, Operations | 215.0K | 10.4K | — | 48.7K | 53.8K | 2.0K | 329.9K | 14.76% | ↗ |
| 73 | 2011 | Daniel P. Witt Senior Vice President, Global Operations | 215.0K | 10.4K | — | 48.7K | 53.8K | 2.0K | 329.9K | 14.76% | ↗ |
| 74 | 2011 | William J. Kelly Chief Financial Officer | 200.0K | — | — | 48.7K | 49.6K | 2.0K | 300.2K | 16.22% | ↗ |
| 75 | 2011 | William J. Kelly Chief Accounting Officer | 200.0K | — | — | 48.7K | 49.6K | 2.0K | 300.2K | 16.22% | ↗ |
| 76 | 2010 | Walter C. Herlihy, Ph.D. President and Chief Executive Officer | 372.0K | — | — | — | 158.3K | 2.0K | 532.3K | 0.00% | ↗ |
| 77 | 2010 | Walter C. Herlihy President and Chief Executive Officer | 372.0K | — | — | — | 158.3K | 2.0K | 532.3K | 0.00% | ↗ |
| 78 | 2010 | James R. Rusche, Ph.D. Senior Vice President, Research and Development | 251.0K | — | — | — | 60.5K | 2.0K | 313.5K | 0.00% | ↗ |
| 79 | 2010 | James R. Rusche Senior Vice President, Research and Development | 251.0K | — | — | — | 60.5K | 2.0K | 313.5K | 0.00% | ↗ |
| 80 | 2010 | Daniel P. Witt, Ph.D. Vice President, Operations | 209.0K | — | — | — | 49.6K | 2.0K | 260.6K | 0.00% | ↗ |
| 81 | 2010 | Daniel P. Witt Senior Vice President, Global Operations | 209.0K | — | — | — | 49.6K | 2.0K | 260.6K | 0.00% | ↗ |
| 82 | 2010 | William J. Kelly Chief Accounting Officer | 194.0K | — | — | — | 43.3K | 2.0K | 239.3K | 0.00% | ↗ |
| 83 | 2010 | William J. Kelly Chief Financial Officer | 194.0K | — | — | — | 43.3K | 2.0K | 239.3K | 0.00% | ↗ |
| 84 | 2009 | Walter C. Herlihy President and Chief Executive Officer | 365.0K | — | — | 369.6K | 149.1K | 2.0K | 885.7K | 41.73% | ↗ |
| 85 | 2009 | Walter C. Herlihy, Ph.D. President and Chief Executive Officer | 365.0K | — | — | 369.6K | 149.1K | 2.0K | 885.7K | 41.73% | ↗ |
| 86 | 2009 | James R. Rusche, Ph.D. Senior Vice President, Research and Development | 246.0K | — | — | 184.8K | 61.3K | 2.0K | 494.1K | 37.40% | ↗ |
| 87 | 2009 | James R. Rusche Senior Vice President, Research and Development | 246.0K | — | — | 184.8K | 61.3K | 2.0K | 494.1K | 37.40% | ↗ |
| 88 | 2009 | Daniel P. Witt Senior Vice President, Global Operations | 205.0K | — | — | 184.8K | 45.9K | 2.0K | 437.7K | 42.22% | ↗ |
| 89 | 2009 | Daniel P. Witt, Ph.D. Vice President, Operations | 205.0K | — | — | 184.8K | 45.9K | 2.0K | 437.7K | 42.22% | ↗ |
| 90 | 2009 | William J. Kelly Chief Financial Officer | 190.0K | — | — | — | 46.0K | 2.0K | 238.0K | 0.00% | ↗ |
| 91 | 2008 | Daniel W. Muehl Chief Financial Officer William J. Kelly | 344.0K | — | — | 89.2K | 103.3K | 2.0K | 538.5K | 16.56% | ↗ |
| 92 | 2008 | Walter C. Herlihy, Ph.D. President and Chief Executive Officer | 344.0K | — | — | — | 103.3K | 2.0K | 449.3K | 0.00% | ↗ |
| 93 | 2008 | William J. Kelly Chief Financial Officer | 521.00 | — | 24.1K | 301.6K | — | — | 326.2K | 99.84% | ↗ |
| 94 | 2008 | James R. Rusche, Ph.D. Senior Vice President, Research and Development | 234.0K | — | — | — | 46.8K | 2.0K | 282.8K | 0.00% | ↗ |
| 95 | 2008 | Daniel P. Witt, Ph.D. Vice President, Operations | 198.0K | — | — | — | 37.4K | 2.0K | 237.4K | 0.00% | ↗ |
| 96 | 2008 | James R. Rusche, Ph.D. Senior Vice President, Research and Development | 74.5K | — | — | 34.3K | — | — | 108.8K | 31.53% | ↗ |
| 97 | 2008 | Daniel P. Witt, Ph.D. Vice President, Operations | 521.00 | — | 63.00 | 160.00 | — | — | 744.00 | 29.97% | ↗ |
| 98 | 2007 | Walter C. Herlihy, Ph.D. President and Chief Executive Officer | 334.0K | — | — | 122.6K | 82.6K | 1.2K | 540.4K | 22.69% | ↗ |
| 99 | 2007 | Walter C. Herlihy, Ph.D. President and Chief Executive Officer | 334.0K | — | — | 122.6K | 82.6K | 1.2K | 540.4K | 22.69% | ↗ |
| 100 | 2007 | Daniel W. Muehl Chief Financial Officer | 200.0K | — | 33.2K | 101.3K | 33.4K | 1.2K | 369.2K | 36.44% | ↗ |
| 101 | 2007 | Daniel W. Muehl Chief Financial Officer William J. Kelly | 200.0K | — | 33.2K | 101.3K | 33.4K | 1.2K | 369.2K | 36.44% | ↗ |
| 102 | 2007 | Daniel P. Witt, Ph.D. Vice President, Operations | 227.0K | — | — | 54.8K | 38.3K | 1.2K | 321.3K | 17.05% | ↗ |
| 103 | 2007 | James R. Rusche, Ph.D. Senior Vice President, Research and Development | 227.0K | — | — | 54.8K | 38.3K | 1.2K | 321.3K | 17.05% | ↗ |
| 104 | 2007 | Daniel P. Witt, Ph.D. Vice President, Operations | 192.0K | — | — | 45.3K | 30.5K | 1.2K | 269.0K | 16.85% | ↗ |
| 105 | 2006 | Daniel W. Muehl Chief Financial Officer | 200.0K | — | 41.3K | — | — | — | 241.3K | 17.12% | ↗ |
| 106 | 2005 | Walter C. Herlihy, Ph.D. President and Chief Executive Officer | 310.0K | 23.0K | — | — | — | — | 333.0K | 0.00% | ↗ |
| 107 | 2005 | James R. Rusche, Ph.D. Senior Vice President, Research and Development | 211.0K | 15.0K | — | — | — | — | 226.0K | 0.00% | ↗ |
| 108 | 2005 | Daniel P. Witt, Ph.D. Vice President, Business Development | 178.0K | 13.0K | — | — | — | — | 191.0K | 0.00% | ↗ |
| 109 | 2004 | Walter C. Herlihy, Ph.D. President and Chief Executive Officer | 300.0K | 20.0K | — | — | — | — | 320.0K | 0.00% | ↗ |
| 110 | 2004 | Walter C. Herlihy, Ph.D. President and Chief Executive Officer | 300.0K | 20.0K | — | — | — | — | 320.0K | 0.00% | ↗ |
| 111 | 2004 | James R. Rusche, Ph.D. Senior Vice President, Research and Development | 204.0K | 13.5K | — | — | — | — | 217.5K | 0.00% | ↗ |
| 112 | 2004 | James R. Rusche, Ph.D. Senior Vice President, Research and Development | 204.0K | 13.5K | — | — | — | — | 217.5K | 0.00% | ↗ |
| 113 | 2004 | Daniel P. Witt, Ph.D. Vice President, Business Development | 172.0K | 11.5K | — | — | — | — | 183.5K | 0.00% | ↗ |
| 114 | 2004 | Daniel P. Witt, Ph.D. Vice President, Business Development | 172.0K | 11.5K | — | — | — | — | 183.5K | 0.00% | ↗ |
| 115 | 2003 | Walter C. Herlihy, Ph.D. President and Chief Executive Officer | 265.0K | 65.0K | — | — | — | — | 330.0K | 0.00% | ↗ |
| 116 | 2003 | Walter C. Herlihy, Ph.D. President and Chief Executive Officer | 265.0K | 65.0K | — | — | — | — | 330.0K | 0.00% | ↗ |
| 117 | 2003 | James R. Rusche, Ph.D. Senior Vice President, Research and Development | 192.0K | 25.0K | — | — | — | — | 217.0K | 0.00% | ↗ |
| 118 | 2003 | James R. Rusche, Ph.D. Senior Vice President, Research and Development | 192.0K | 25.0K | — | — | — | — | 217.0K | 0.00% | ↗ |
| 119 | 2003 | Daniel P. Witt, Ph.D. Vice President, Business Development | 162.0K | 20.0K | — | — | — | — | 182.0K | 0.00% | ↗ |
| 120 | 2003 | Daniel P. Witt, Ph.D. Vice President, Business Development | 162.0K | 20.0K | — | — | — | — | 182.0K | 0.00% | ↗ |
| 121 | 2002 | Walter C. Herlihy, Ph.D. President and Chief Executive Officer | 242.0K | 50.0K | — | — | — | — | 292.0K | 0.00% | ↗ |
| 122 | 2002 | James R. Rusche, Ph.D. Senior Vice President, Research and Development | 172.0K | 25.0K | — | — | — | — | 197.0K | 0.00% | ↗ |
| 123 | 2002 | Daniel P. Witt, Ph.D. Vice President, Business Development | 152.0K | 20.0K | — | — | — | — | 172.0K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Olivier Loeillot | President, Chief Executive Officer & Director | 2M | male |
| Jason K. Garland | Chief Financial Officer & Chief Compliance Officer | 1M | male |
| James R. Bylund | Chief Operating Officer | 856.0K | male |
| Ralf Kuriyel | Senior Vice President of Research & Development | 749.1K | male |
| Anthony J. Hunt | Advisor | 671.0K | male |
| Brian Douglass | Senior VP & Chief Product Officer | 638.1K | male |
| Daniel Witt | Senior Advisor | 287.7K | — |
| Michael Martino | Chief Information Officer | — | male |
| Neil Whitfield | Senior Vice President of Sales | — | male |
| Steven Chehames | Director of Investor Relations | — | male |
| Jacob K. Johnson | Vice President of Investor Relations | — | male |
| Violetta Hughes | Chief Accounting Officer | — | female |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-07-22 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2025-06-17 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2025-06-11 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2022-04-11 | 2022-05-06 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2022-02-17 | 2022-03-08 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2022-01-20 | 2022-02-08 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2022-01-11 | 2022-02-08 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RGEN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
